Carna Biosciences, Inc. ("Carna") announced on October 27, 2008, the signing of a Distribution Agreement with Shanghai Universal Biotech Company ("SUBC"). Under the terms of this Agreement, SUBC will become the exclusive distributor of Carna's Protein Kinases within China.

On September 19,2008, under the resolution at the board of directors meeting, Carna Biosciences,Inc. will dissolve the distributor contact with Toyobo Co.,Ltd. on September 30.

Carna Biosciences set up Director Stock Ownership Plan("DSOP")and Employee Stock Ownership Plan ("ESOP").

Kobe, Japan, August 6, 2008 Carna Biosciences, Inc.(“Carna”) is pleased to announce the signing of a collaborative agreement with caliper Life Sciences, Inc. USA (“Caliper”). Carna will supply a set of discrete protein kinases aiding the expansion of Caliper’s kinase profiling and assay development services, and ProfilerPro Kinase Selectivity Assay Kits. Caliper’s products and services are widely used and highly regarded by leading pharmaceutical and biotech companies. The selection of Carna as a Preferred Provider enhances the visibility and use of Carna’s products in the area of kinase inhibitor drug discovery – a major focus of targeted therapy in the areas of cancer, neurological, and autoimmune diseases.

Carna Biosciences has decided to establish wholly-owned subsidiary, CarnaBio USA, Inc., located in Massachusette, USA. This is to meet an increasing demand of customers of North America that we will be able to provide our kinase related products and services in a timely manner. Operation is scheduled to start in June, 2008.